You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 8, August 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Should Portosystemic Shunt Be Reconsidered in the Treatment of Intractable Ascites in Cirrhosis?

Dominique Franco, MD; Corinne Vons, MD; Oscar Traynor, MCh, FRCSI; Claude de Smadja, MD

Arch Surg. 1988;123(8):987-991.


Abstract

• Fifty-seven cirrhotic patients with intractable ascites had a portosystemic shunt. In 35 patients, a peritoneovenous shunt had previously failed. Forty-six patients were in Pugh's class B and 11 were in class C. There were three operative deaths (5.3%). Fifty-three (98.2%) of the 54 survivors were cleared of ascites. In one patient, ascites persisted because of postshunt heart failure that resulted in a marked increase of caval pressure. Twenty-seven patients (50%) had late encephalopathy, which was severe and disabling in 12 (22%). One- and three-year survival rates were 72% and 36%, respectively. These results suggest that although portosystemic shunts are remarkably effective in dealing with ascites, the high rate of postoperative encephalopathy is a strong argument against their routine use in the management of intractable ascites in cirrhosis.

(Arch Surg 1988;123:987-991)



Author Affiliations

From the Department of Research on Surgery of the Liver of Portal Hypertension, University of Paris-Sud, Hôpital Paul Brousse, Villejuif, France.


Footnotes

Accepted for publication July 20, 1987.

Reprint requests to Hôpital Paul Brousse, F-94804 Villejuif Cédex, France (Dr Franco).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The cardiac response to exercise in cirrhosis
Wong et al.
Gut 2001;49:268-275.
ABSTRACT | FULL TEXT  

Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome
Suzuki and Stanley
QJM 2001;94:293-300.
ABSTRACT | FULL TEXT  

The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Refractory Ascites
Ochs et al.
NEJM 1995;332:1192-1197.
ABSTRACT | FULL TEXT  

Comparison of Transjugular and Surgical Portosystemic Shunts on the Outcome of Liver Transplantation
Menegaux et al.
Arch Surg 1994;129:1018-1024.
ABSTRACT  

Care of Patients with Ascites
Kaufman et al.
NEJM 1994;330:1827-1828.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.